SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-318205
Filing Date
2020-12-15
Accepted
2020-12-15 17:09:28
Documents
4
Period of Report
2020-12-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d70415d8k.htm 8-K 22907
2 EX-1.1 d70415dex11.htm EX-1.1 185955
3 EX-5.1 d70415dex51.htm EX-5.1 7848
4 GRAPHIC g70415g96g01.jpg GRAPHIC 3088
  Complete submission text file 0001193125-20-318205.txt   222190
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 201390309
SIC: 2834 Pharmaceutical Preparations